Pancreatic cancer: Advances and challenges

Halbrook, Christopher J., Lyssiotis, Costas A., Pasca di Magliano, Marina, Maitra, Anirban·2023·Cell
DOI 10.1016/j.cell.2023.02.014

Cited by (999)

Items 701–800 of 999

  1. Significance of Tumor Microenvironment for Regulating Pancreatic Cancer
    Hideaki Ijichi · 2023 · Cancers
  2. Diagnosis and prognosis of pancreatic cancer with immunoglobulin heavy constant delta blood marker
    Qiyang Chen, Qingsong Guo, Dongzhi Wang, Shajun Zhu, Di Wu, Zhiwei Wang, Yuhua Lu · 2023 · Journal of Cancer Research and Clinical Oncology
  3. A niche-mimicking polymer hydrogel-based approach to identify molecular targets for tackling human pancreatic cancer stem cells
    Yoshitaka Murota, Mariko Nagane, Mei Li Wu, Mithun Santra, Seshasailam Venkateswaran, Shinji Tanaka, Mark Bradley, Tetsuya Taga, Kouichi Tabu · 2023 · Inflammation and Regeneration
  4. Pancreatic Cancer-Secreted Proteins: Targeting Their Functions in Tumor Microenvironment
    Anna Lisa Cammarota, Antonia Falco, Anna Basile, Carlo Molino, Massimiliano Chetta, Gianni D’Angelo, Liberato Marzullo, Margot De Marco, Maria Caterina Turco, Alessandra Rosati · 2023 · Cancers
  5. Study on the application value of fluorescent laparoscopy in pancreatic tumor surgery
    Shihang Xi, Wei Zhang, Daohai Qian, Chiyi He, Xueliang Zuo, Juan Cai, Lin Li, Huiming Cai, Chawla Akhil, Xiaoming Wang · 2023 · Gland Surgery
  6. Multidimensional screening of pancreatic cancer spheroids reveals vulnerabilities in mitotic and cell-matrix adhesion signaling that associate with metastatic progression and decreased patient survival
    Albert-Fred Aquino, Farhana Runa, Jannatul F. Shoma, Audrey Todd, Matthew Wallace, Natan Roberto de Barros, Jonathan A. Kelber · 2024 · Biochemical and Biophysical Research Communications
  7. Correlation between main pancreatic duct diameter measurements: Special pancreatic ultrasonography versus magnetic resonance cholangiopancreatography
    Kenji Ikezawa, Junko Fukuda, Miho Nakao, Yoko Nakano, Chiaki Higashi, Mayumi Chagi, Yasuhiro Nakaya, Kazuyoshi Ohkawa · 2024 · Medicine
  8. CUL4A Ubiquitin Ligase Is an Independent Predictor of Overall Survival in Pancreatic Adenocarcinoma
    Panagiotis Tavlas, Sofia Nikou, Christina Geramoutsou, Pinelopi Bosgana, Spyridon Champeris Tsaniras, Maria Melachrinou, Ioannis C. Maroulis, Vasiliki Bravou · 2024 · Cancer Genomics & Proteomics
  9. Disruption of the pro-oncogenic c-RAF–PDE8A complex represents a differentiated approach to treating KRAS–c-RAF dependent PDAC
    Sean F Cooke, Thomas A. Wright, Yuan Yan Sin, Jiayue Ling, Elka Kyurkchieva, Nattaporn Phanthaphol, Thomas Mcskimming, Katharine J. Herbert, Selma Rebus, Andrew Victor Biankin et al. · 2024 · Scientific Reports
  10. Pancreatic Diseases: Genetics and Modeling Using Human Pluripotent Stem Cells
    Yuri Lee, Kihyun Lee · 2024 · International Journal of Stem Cells
  11. Illuminating the path to pancreatic cancer
    Hiroyuki Kato, Nabeel M. Bardeesy · 2024 · Cell Research
  12. Genetic and immune identification and functional analysis of TRPM8 as a potential biomarker for pancreatic adenocarcinoma proliferation
    Sen Qiao, Fengming Wu, Hongmei Wang · 2024 · Cancer Reports
  13. Emerging and extensive clonal evolution in the pancreas
    Alvin P. Makohon-Moore · 2024 · Trends in cancer
  14. Serplulimab combined with gemcitabine, nab-paclitaxel and stereotactic body radiotherapy as the first-line treatment for patients with metastatic pancreatic adenocarcinoma in China: a multicentre, single-arm, phase II trial (ICSBR) protocol
    Chenyan Zhang, Heqi Yang, Chang Chen, Ruizhen Li, Junjie Xiong, Deying Kang, Du He, Xi-Jiao Liu, Ke Cheng, Dan Cao · 2024 · BMJ Open
  15. Sarcomatoid carcinoma of the pancreas (Review)
    Yijie Ma, Yiwen Yang, Huizhi Zhang, Joseph Mugaanyi, Yangke Hu, Shengdong Wu, Caide Lu, Shuqi Mao, Ke Wang · 2024 · Oncology Letters
  16. Nanoparticles Bounded to Interfering RNAs as a Therapy for Pancreatic Cancer: A Systematic Review
    Patricia Lara, Francisco Quiñonero, Raúl Ortíz, Jose Carlos Prados, Consolación Melguizo · 2024 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
  17. Screening, optimization, and ADMET evaluation of HCJ007 for pancreatic cancer treatment through active learning and dynamics simulation
    Yunyun Xu, Qiang Wang, GaoQiang Xu, YouJian Xu, Yiping Mou · 2024 · Frontiers in Chemistry
  18. Analyzing the high frequency of false-positive carcinoembryonic antigen elevations in postoperative pancreatic ductal adenocarcinoma
    Haruka Tanaka, Yoshihiro Mise, Atsushi Takahashi, Fumihiro Kawano, Yoshinori Takeda, Hiroshi Imamura, Hirofumi Ichida, Ryuji Yoshioka, Akio Saiura · 2024 · Langenbeck s Archives of Surgery
  19. PMDC: Pancreas Segmentation with Mamba Block and Deformable 3D Convolution
    Ziyao Meng, Yiming Qin, Tianyi Wang, Hao Shen, Yang Liu, Jie Dong, Haitao Song · 2024 · IEEE International Conference on Bioinformatics and Biomedicine (BIBM)
  20. The known genetic variants of BRCA1, BRCA2 and NOD2 in pancreatitis and pancreatic cancer risk assessment
    Jarosław Matykiewicz, Wioletta Adamus-Białek, Monika Wawszczak-Kasza, Bartosz Molasy, Magdalena Kołomańska, Ruslan Obłap, Łukasz Madej, Dorota Kozieł, Stanisław Głuszek · 2025 · Scientific Reports
  21. Lipids, lipid-lowering drug target genes and pancreatic cancer: a Mendelian randomization study
    Yuxuan Zhan, Kai Zhang, Yiqun Fan, Siyi Lin, Jian Wu, Hongxia Xu, Hongxia Xu · 2025 · International Journal of Clinical Pharmacy
  22. TRAIL receptor agonist TLY012 in combination with PD-1 inhibition promotes tumor regression in an immune-competent mouse model of pancreatic ductal adenocarcinoma
    Anna D. Louie, Kelsey E. Huntington, Young Shin Lee, Jared Mompoint, Laura Jinxuan Wu, Seulki Lee, Thomas J. Miner, Wafik S. El‐Deiry · 2025 · American Journal of Cancer Research
  23. IDENTIFICATION AND GLOBAL INTERPRETATION OF POSSIBLE BIOMARKERS FOR THE DIAGNOSIS OF PANCREATIC CANCER USING EXPLAINABLE ARTIFICIAL INTELLIGENCE METHODS
    Şeyma Yaşar · 2025 · İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi
  24. Plasma treatment can efficiently increase the attachment of pancreatic circulatory tumor cells to the surface
    Seyed Mohammad Amin Mahdian, Azam Mahmoudi-Aznaveh, Seyed Mojtaba Mousavi, Bagher A. Larijani, Zahra Azizi, Hamid Akbari Javar · 2025 · Discover Oncology
  25. Multi-Omics Profiling Reveals Glycerolipid Metabolism-Associated Molecular Subtypes and Identifies ALDH2 as a Prognostic Biomarker in Pancreatic Cancer
    Jifeng Liu, Shurong Ma, Dawei Deng, Yao Yang, Junchen Li, Yunshu Zhang, Peiyuan Yin, Dong Shang · 2025 · Metabolites
  26. Correlation of MRI characteristics with KRAS mutation status in pancreatic ductal adenocarcinoma
    Junjian Shen, Xingxing Wang, Keqin Yu, Kai Liu, Xiaolin Wang, Haitao Sun, Jianjun Zhou, Mengsu Zeng · 2025 · Abdominal Radiology
  27. Unlocking the Genetic Secrets of Pancreatic Cancer: KRAS Allelic Imbalances in Tumor Evolution
    Vasiliki Liaki, Blanca Rosas-Pérez, Carmen E. Guerra · 2025 · Cancers
  28. Carbon‐ion irradiation together with autophagy inhibition and immune checkpoint inhibitors protect against pancreatic cancer development in mouse model
    Makoto Sudo, Yaoyao Wang, Jingren Wang, Koubun Yasuda, Keiko Mitani, Shuhei Hayashi, Masaki Ohmuraya, Hiroko Tsutsui, Jiro Fujimoto · 2025 · Journal of Hepato-Biliary-Pancreatic Sciences
  29. Exploring the genetic link between gastroesophageal reflux disease and pancreatic cancer: insights from Mendelian randomization
    Chen Yang, Fan Ge, Mengye Peng, Liang Cheng, Kezheng Wang, Wei Yong Liu · 2025 · BMC Cancer
  30. Burrowing Behavior as Robust Parameter for Early Humane Endpoint Determination in Murine Models for Pancreatic Cancer
    Jakob Brandstetter, Lisa Hoffmann, Ingo Koopmann, Tim Schreiber, Benjamin Schulz, Stephan P. Rosshart, Dietmar Zechner, Brigitte Vollmar, Simone Kumstel · 2025 · Animals
  31. Impact of zinc deficiency on the prognosis of unresectable pancreatic cancer
    Yusuke Seiki, Kenji Ikezawa, Yugo Kai, Ryoji Takada, Masaki Kawabata, Hiroki Kishimoto, Kana Hosokawa, Ko Watsuji, Kazuhiro Kozumi, Makiko Urabe et al. · 2025 · Pancreatology
  32. Development of [18F]AlF-RESCA-H006 as a Novel Molecular Probe for 5T4 Tumor Imaging and Exploration of Its Application in Pancreatic Adenocarcinoma
    Jinping Kong, Huixia Zhang, Ruhua Tian, Wenjie Ge, Yingfang He, Tengxiang Chen, Junbin Han · 2025 · Molecular Pharmaceutics
  33. Unraveling the therapeutic landscape of miRNAs in pancreatic cancer
    Zeinab A. El‐Moaty, Maria Wagdy Wasef, Y. A. Elsayed, Amina Sayed Shafiq, Mai A Elnagar, Hadeer Rashad Mohamed, Ahmed E Elesawyf, Sherif S. Abdel Mageed, Osama A. Mohammed, Mustafa Ahmed Abdel‐Reheim et al. · 2025 · Naunyn-Schmiedeberg s Archives of Pharmacology
  34. Shifting Trends in Pancreatic Cancer Incidence Across Generations in Spain (1992-2021)
    Lucía Cayuela, Victoria Achaval, Gema Flox-Benítez, Aurelio Cayuela · 2025 · Revista Española de Enfermedades Digestivas
  35. STAT3 sustains tumorigenicity following mutant KRAS ablation
    Stephen D’Amico, Varvara Kirillov, Jingxuan Liu, Zhijuan Qiu, Xinyuan Lei, Hong Qin, Brian S. Sheridan, Nancy C. Reich · 2025 · EMBO Reports
  36. Glycaemic control is a modifiable risk factor for pancreatic cancer development in patients with diabetes: a population-based cohort study
    Jing Tong Tan, Xianhua Mao, David Tak Wai Lui, Chang Li, Ho Ming Cheng, Wai K. Leung, Wai‐Kay Seto, Ka Shing Cheung · 2025 · Gut
  37. Network pharmacology and experimental study on the inhibition of glycolysis by amentoflavone in pancreatic cancer
    Xu He, Peng Chen, Zhihao Zhao, HyokChol Choe, Tanveer Ali, Kaiyue Ding, Xingchen Wu, Junnan Ma, Lin Zhang · 2025 · Discover Oncology
  38. S100s and HMGB1 Crosstalk in Pancreatic Cancer Tumors
    Angelo Mandarino, Swetha Thiyagarajan, Allana Cristina Faustino Martins, Roberto da Silva Gomes, Stefan W. Vetter, Estelle Leclerc · 2023 · Biomolecules
  39. Inhibition of the Complement Pathway Induces Cellular Proliferation and Migration in Pancreatic Ductal Adenocarcinoma
    Zanele Nsingwane, Previn Naicker, J. Omoshoro–Jones, John WS Devar, Martin Smith, Geoffrey Patrick Candy, Tanya Nadine Augustine, Ekene Emmanuel Nweke · 2023 · medRxiv
  40. Msln Induced Emt, Cancer Stem Cell Traits and Chemotherapy Resistance of Pancreatic Cancer Cells
    Jili Hu, Wang Jia, Xu Guo, Qing Fan, Xinming Li, Kai Li, Zhuoyin Wang, Shuntao Liang, Amin Buhe, Nengwei Zhang et al. · 2024 · SSRN Electronic Journal
  41. Trends and hotspots of prognostic factors for pancreatic ductal adenocarcinoma from 2013 to 2022
    Jieyu Peng, Muhan Lv, Yan Peng, Xiaowei Tang · 2024 · HepatoBiliary Surgery and Nutrition
  42. Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: Synthesis, mechanistic Insights and promising antitumor and safety profile
    Daniela Carbone, Camilla Pecoraro, Fabio Scianò, Francesca Terrana, Geng Xu, Cecilia Bergonzini, Margot S. F. Roeten, Stella Cascioferro, Girolamo Cirrincione, Patrizia Diana et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  43. Multiethnic radiogenomics reveals low-abundancy microRNA signature in plasma-derived extracellular vesicles for early diagnosis and subtyping of pancreatic cancer
    Wenjie Shi, Jianying Xu, Yi Zhun Zhu, Chao Zhang, Julia Nagelschmitz, Maximilian Doelling, Sara Al-Madhi, Ujjwal Mukund Mahajan, Maciej Pech, Georg Rose et al. · 2025 · eLife
  44. A decade of patient-derived organoids in pancreatic cancer: points in translation
    Marcus T. T. Roalsø, Daniel Öhlund, Kjetil Søreide · 2025 · Scandinavian Journal of Gastroenterology
  45. KRAShing pancreatic cancer before takeoff
    Benjamin G. Neel, Anirban Maitra · 2026 · Science
  46. Multi-Algorithm Analysis Reveals Pyroptosis-Linked Genes as Pancreatic Cancer Biomarkers
    Kangtao Wang, Shanshan Han, Li Liu, Zhao Lian, Ingrid Herr · 2024 · Cancers
  47. Case report: Diverse immune responses in advanced pancreatic ductal adenocarcinoma treated with immune checkpoint inhibitor-based conversion therapies
    Xiaoying Li, Chaoxin Xiao, Ruizhen Li, Pei Zhang, Heqi Yang, Dan Cao · 2024 · Frontiers in Immunology
  48. Pharmacological mechanisms underlying the interaction of the nucleoside analogue gemcitabine with the c-MET inhibitor tivantinib in pancreatic cancer
    Mahrou Vahabi, Geng Xu, Amir Avan, Godefridus J. Peters, Elisa Giovannetti · 2024 · Nucleosides Nucleotides & Nucleic Acids
  49. Solute carrier family 16 member 1 as a potential prognostic factor for pancreatic ductal adenocarcinoma and its influence on tumor immunity
    Meng Wang, Lin Liu, Xinze Li, Wenna Jiang, Jiawei Xiao, Qianhui Hao, Jia‐Yi Wang, Abhinav V. Reddy, Alice Talbot, Shinichi Ikuta et al. · 2024 · Journal of Gastrointestinal Oncology
  50. SSH3 promotes pancreatic cancer proliferation and migration by activating the notch signaling pathway
    Chengxiao Yang · 2024 · American Journal of Cancer Research
  51. A Recent Overview of the Growing Applications of Biosimilars in Pancreatic Cancer Management: Current Picture and Future Perspectives
    Dhruv Gupta, Daksh Sanjay Gupta, Saritha Rakesh Shetty · 2024 · Springer eBooks
  52. Robotic pancreaticoduodenectomy in patients with overweight or obesity: a meta-analysis protocol
    Wenxiao Yang, Hai Zeng, Yueling Jin · 2024 · BMJ Open
  53. Ex-Vivo 3D Cellular Models of Pancreatic Ductal Adenocarcinoma
    Ivana Aćimović, Viktorie Gabrielová, Stanislava Martínková, Michal Eid, Jakub Vlažný, Petr Moravčík, Jan Hlavsa, Lukáš Moráň, Riza Can Cakmakci, Peter Staňo et al. · 2024 · Pancreas
  54. Canadian National Pancreas Conference 2023: A Review of Multidisciplinary Engagement in Pancreatic Cancer Care
    Jessica L. Nickerson, Chloe Cyr, Riley J. Arseneau, Stacey N. Lee, Stefanie Condon-Oldreive, George Zogopoulos, Keith John Roberts, Christina Kim, Sylvia S. W. Ng, Masoom A. Haider et al. · 2024 · Current Oncology
  55. T-shaped probe system with low detection limits, versatility and low cost for multiple mutation detection
    Yangwei Liao, Hang Zhang, Taoyuan Yin, Zhenxiong Zhang, Jun Gong, Shutao Pan, Renyi Qin · 2024 · Sensors and Actuators B Chemical
  56. Metastatic pancreatic cancer now in remission: a case report and literature review
    Charles W Shi, Thomas J. VanderMeer, Anita Pudusseri · 2025 · Discover Oncology
  57. CT-based machine learning radiomics predicts Ki-67 expression level and its relationship with overall survival in resectable pancreatic ductal adenocarcinoma
    Jia-Hao Chen, Zhuangxuan Ma, Yamin Xu, Jieqiong Ge, Hong‐Fei Yao, Chunjing Li, Xiao Hu, Yunlong Pu, Ming Li, Chongyi Jiang · 2025 · Abdominal Radiology
  58. GALNT5 promotes migration and invasion of pancreatic ductal adenocarcinoma cells by activating Erk signaling pathway
    Yongjia Zheng, Yao Lu, Yuan Fang, Yun Kong, Yang Mao, Shengjun Wang · 2025 · Biochimica et Biophysica Acta (BBA) - General Subjects
  59. Infrared Imaging Combined with Machine Learning for Detection of the (Pre)Invasive Pancreatic Neoplasia
    Danuta Liberda, Kinga B. Stopa, Daria Krzysztofik, Paweł E. Ferdek, Monika Joanna Jakubowska, Tomasz P. Wróbel · 2025 · ACS Pharmacology & Translational Science
  60. Increased Herpesvirus Entry Mediator Expression on Circulating Monocytes and Subsets Predicts Poor Outcomes in Pancreatic Ductal Adenocarcinoma Patients
    Isabelle Kuchenreuther, Finn-Niklas Clausen, Johanne Mazurie, Sushmita Paul, Franziska Czubayko, Anke Mittelstädt, Ann‐Kathrin Koch, Alara Karabiber, Frederik J. Hansen, Lisa-Sophie Arnold et al. · 2025 · International Journal of Molecular Sciences
  61. Comprehensive analysis of UPK3B as a marker for prognosis and immunity in pancreatic adenocarcinoma
    Ziying Jian, Tao Pan, Renjie Li, Weiyu Zhang, Tao Cheng, Hanzhe Zhang, Jialin Song, Naipeng Shi, Zhiheng Zhang · 2025 · Scientific Reports
  62. Nano-drug codelivery system of vincristine and gemcitabine loaded hyaluronan-altered hollow mesoporous silica nanoparticles: investigation of in vitro drug release and anticancer activity in pancreatic cancer cells
    Huimin Wu, Ze-Kun Zhao, Xinxing Li, Shenglan Wang, Kaixing Ai · 2025 · Naunyn-Schmiedeberg s Archives of Pharmacology
  63. Nanoemulsion-based nanoplatform as a new PEITC nano - delivery system to pancreatic cancer cells
    Aleksandra Grzeszczak, Magdalena Zaremba-Czogalla, Agnieszka Zagórska, Maria Walczak, Maciej Tadeusz Gawlik, Robert Żarnowski, David R. Andes, Jerzy Gubernator, Anna Jaromin · 2025 · Journal of Drug Delivery Science and Technology
  64. Ultrasound‐Responsive Lipid Nanosonosensitizers with Size Reduction and NO Release: Synergistic Sonodynamic‐Chemo‐Immunotherapy for Pancreatic Tumors
    Leyi Fang, Wenhui Zeng, Yili Liu, Yinxing Miao, Chunmei Lu, Zhonghan Xu, Sensen Zhou, Qi Xue, Yi‐Tong Xu, Xiqun Jiang et al. · 2025 · Angewandte Chemie
  65. DNMT1 ‐Induced Downregulation of CBX7 Inhibits ERK Phosphorylation and Promotes Pancreatic Ductal Adenocarcinoma Progression
    Haowei Shi, Xu Liu, Xing Cheng, Shiqi Guo, Yangyang Zheng, Wen Tan, Yunpeng Ge, Jingyong Xu, Yao Li, Jinghai Song · 2025 · The FASEB Journal
  66. Surgical Resection of Murine PDAC Alters Hepatic Metastases and Immune Microenvironment
    Anthony P. Sorrentino, Carolina Alcantara Hirsch, Beny Shapiro, Erica Ma, Emma Kurz, Mansour E. Riachi, Sarah R. Kaslow, Ting Chen, Wenqing Cao, Ryte Damaseviciute et al. · 2025 · Pancreas
  67. ASO Therapy Targeting STAU2 to Inhibit Pancreatic Ductal Adenocarcinoma Progression and Metastasis by Regulating the PALLD‐Mediated EMT Signaling Pathway
    Jiayu Ding, Hao Shen, Jiaying Ji, Jia Li, Zhongrui Shi, Xuejiao Wang, Bangbang Li, Yi Hou, Wenjian Min, Chengliang Sun et al. · 2025 · Advanced Science
  68. Innate lymphoid cells in pancreatic ductal adenocarcinoma: Immune regulation and therapeutic implications
    Tinghui Mao, Wenjiao Teng, Lin Li, Wei Zhou · 2025 · Cancer Letters
  69. The long antisense non-coding RNA HOXA transcript at the distal tip (LncRNA HOTTIP) in health and disease: a comprehensive review and in silico analysis
    Mona G El-Sisi, Sara M. Radwan, Sameh Saad Ali, Mohamed Y. Mostafa, Nadia Μ. Hamdy · 2025 · Naunyn-Schmiedeberg s Archives of Pharmacology
  70. PLAGL2 as a prognostic biomarker and an EMT-promoting factor in PDAC
    Yanhui Yang, Hao Wang, Zhe-Hua Xing, Qian-Qian Bai, Weifeng Liu, Dahuan Li, Chi Zhang, Shu-Min Zhang, Fang-Fei Liu, Yubo Liu et al. · 2025 · Scientific Reports
  71. Identification of a fibroblast-derived gene signature reveals prognostic and therapeutic insights in pancreatic cancer
    Wenjia Wang, Heli Li, Jun Gong, Yuhui Liu · 2025 · Clinical and Experimental Medicine
  72. A scoring model for preoperative differentiation of high-enhancement pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis
    Jiaping Zhou, Xiaojie Wang, Haifeng Zhang, Yao Pan, Weilin Wang, Risheng Yu · 2025 · BMC Medical Imaging
  73. Comparative spatial transcriptomics of pancreatic cancer with ductal and acinar origins in mouse models
    Ming Cui, Jialu Bai, Xiaoyan Chang, Ruiling Xiao, Shengwei Mo, Kevin C. Soares, Sen Yang, Lei You, Quan Liao, Jin Peng He et al. · 2025 · Clinical and Translational Medicine
  74. Neferine induces cell growth inhibition and apoptosis via ROS-mediated activation of p38 in pancreatic ductal adenocarcinoma cells
    Xianfei Zhou, Ming Chen, Renwei Xing, Fan Yang, Hanlin Liu, Siyuan Liang · 2025 · Journal of Molecular Histology
  75. The urokinase receptor/uPAR is a major effector of p53 gain-of-function mutations in gemcitabine-treated pancreatic ductal adenocarcinoma
    Carlotta Zampieri, Kourosh Kouhmareh, Parnian Sartipdolagh, Pardis Azmoon, Richard L. Klemke, Steven L. Gonias · 2025 · Journal of Biological Chemistry
  76. Discovery of a novel RSK2 inhibitor for the treatment of metastatic pancreatic cancer
    Chi-Hsiu Chung, Kai‐Cheng Hsu, Mingmin Huang, Huang‐Ju Tu, Shiow‐Lin Pan, Min‐Wu Chao · 2025 · Journal of Enzyme Inhibition and Medicinal Chemistry
  77. A new perspective for the diagnosis of pancreatic cancer: based on the understanding of extracellular vesicle proteins
    Beihan Dong, Yaoyun Zhang, Tingyue Kang, Fujun Wang, Gang Su · 2025 · Expert Review of Molecular Diagnostics
  78. Core-fucosylated glycoproteins as biomarkers for diagnosing pancreatic ductal adenocarcinoma
    Xinyu Zhao, Yi Huang, Jianhui Wu, Aichao Wang, Guoqian Yang, Chunyi Hao, Wantao Ying · 2025 · International Journal of Biological Macromolecules
  79. New Marine-Inspired Oxadiazole Derivatives for Use Against Pancreatic Ductal Adenocarcinoma
    Camilla Pecoraro, Daniela Carbone, Fares Hezam Al-Ostoot, Mahrou Vahabi, Giulia Lencioni, Patrizia Diana, Elisa Giovannetti, Barbara Parrino · 2025 · Marine Drugs
  80. Spatialsmooth: a spatially-aware convolutional autoencoder framework for enhanced deconvolution of spatial transcriptomics data
    Xiao Jing Yang, Jinjin Xiang, Yanbin Feng, Yanfang Zhao, Huamei Li, Xiaozhou Chen · 2025 · BMC Genomics
  81. An image analysis pipeline to quantify the spatial distribution of cell markers in stroma-rich tumors
    Antoine A. Ruzette, Nina V. Kozlova, Kayla A. Cruz, Taru E. Muranen, Simon Flyvbjerg Nørrelykke · 2025 · Frontiers in Bioinformatics
  82. Comparative Analysis of Primary and Liver Fibroblasts Reveals MET as a Potent Target in Pancreatic Cancer Metastasis
    Rima Singh, Natalie Yousefian, Walker M. Allen, Austin D. Silva, Cecily Anaraki, Alica K. Michels, Sabrina E. Calderon, Ian M. Loveless, Daniella Rastelli, Ashley George et al. · 2026 · Cellular and Molecular Gastroenterology and Hepatology
  83. Nitrile and amide integrated pyrazole based molecular hybrids: Synthesis, biological evaluation, and molecular docking studies
    Shunmugam Iniyaval, Kannan Gokula Krishnan, R. Sivasakthikumaran, Chun‐Wai Mai, Chennan Ramalingan · 2025 · Journal of the Indian Chemical Society
  84. Targeting PIN1 in Pancreatic Tumor Microenvironment with Peptide Amphiphiles Unleashes Immune Checkpoint Therapy
    Yuanyuan Wu, Jianan Guo, Yuwei Zhang, Ruizhi Zhao, Wenhao Luo, Chihua Fang · 2025 · Advanced Healthcare Materials
  85. Efficacy of cadonilimab in combination with nimotuzumab and AG regimen in TMB-H/KRAS wild-type advanced pancreatic cancer: a case report
    Zhiwei Tang, Jiegang Hu, ZhongShi He, Dongdong Zhang · 2025 · Frontiers in Immunology
  86. OCIAD2 as a novel prognostic and therapeutic biomarker for pancreatic cancer: A study based on transcriptomic signature and bioinformatics analysis
    Zhongyuan Cui, Xia Lei, Yani Gou, Zhixian Wu, Xiaojun Huang · 2025 · PLoS Computational Biology
  87. Utilizing explainable AI to decipher transcriptomic alterations in pancreatic cancer
    Ankur Datta, Esther Graceia Precious A, Akshata Shetty, Sridhar Raj S, George Priya Doss C · 2025 · Human Gene
  88. Therapeutic cancer vaccines in pancreatic cancer
    Yuhan Wang, Peng Huang, Chun Li, ShengJin Tu, Hua Yang · 2025 · Frontiers in Immunology
  89. Plakophilin 3 drives acinar cell transformation and promotes cancer initiation and progression in pancreas
    Xiaojia Li, Wei Fang, Tingting Jiang, Linyu Zhang, Qihui Sun, Hailin Jiang, Fengjie Guo, He Ren, Wenjun Zheng, Xian Shen et al. · 2025 · Cell Reports
  90. Modeling tumor dynamics and predicting response to therapies in a murine pancreatic cancer model
    Krithik Vishwanath, Hoon Choi, Mamta Gupta, Rong Zhou, Anna G. Sorace, Thomas E. Yankeelov, Ernesto A. B. F. Lima · 2025 · npj Systems Biology and Applications
  91. Inequities in supportive care medication use among older adults with metastatic pancreatic adenocarcinoma
    Alvina Liang, Avirath U. Vaidya, Robert J. Besaw, Arjun Gupta, Stacie B. Dusetzina, Shelley A. Jazowski · 2025 · Supportive Care in Cancer
  92. BNC2 as a novel driver of pancreatic cancer progression through transcriptional regulation of COL3A1 and epithelial-to-mesenchymal transition
    Xiuming Li, Teng Yu, Zheng Yu, Xun Zou, Jingliang He, Dan Wang, Xiaozhu Shen, Shunfang Liu, Bin Liu · 2025 · Medical Oncology
  93. Targeting IRF7 to overcome gemcitabine resistance in pancreatic ductal adenocarcinoma
    Ganghua Yang, Hao-Qi Yan, Zhengyang Lu, Qinhong Xu, Zheng Wang, Shuo Zhao · 2025 · iScience
  94. Comprehensive clinico-genomic analysis of pancreatic ductal adenocarcinoma: Overcoming biases and limitations
    Kwangrok Jung, Jong-Chan Lee, Jin-Ho Kim, Hee Young Na, Jae Hyeong Kim, Yuna Youn, Namyoung Para, Jaihwan Kim, Jin‐Hyeok Hwang · 2025 · Cancer Letters
  95. The effect of circulating CD4+ and CD8+ T cells on the prognosis in advanced postoperative pancreatic adenocarcinoma patients who received chemotherapy
    Qingqing Chang, Hong Xia Fan, Weiwei Si, Jibin Mao · 2025 · Medicine
  96. Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target
    Xiangjun Wang, Weimin Wang, Chuanxin Yang, Puxiongzhi Wang, Yangming Liu, Liqin Yu, Sijie Zhang, Xiaoyu Yan, Jian Wang · 2025 · Frontiers in Immunology
  97. Transcriptional deregulation by FOXM1–JUP signaling confers dual oncogenic drivers for pancreatic tumorigenesis and therapeutic resistance
    Kailing Yang, Zhihong He, Tingting Jiang, Tian Cai, Xiaojia Li, Keping Xie · 2025 · Cell Communication and Signaling
  98. A mitochondria-related gene-based signature predicts pancreatic ductal adenocarcinoma clinical outcome and revealed CAMK2A/THEM4 regulates progression phenotypes and mitophagy in vivo and in vitro
    Gang Nie, Zhongfei Zhu, Jing Huang, Xiaohan Shi, Xiaoyi Yin, Gang Li, Gang Jin · 2025 · Journal of Translational Medicine
  99. Multi-omics analysis reveals cell adhesion molecules as key regulators of immune cell infiltration and adverse outcomes and in vitro validation of CLDN16 in pancreatic adenocarcinoma
    Zewei Zhuo, Jianming Luo, G Liang, Jiahao Li, Qi Yang, Huang Lin · 2025 · Cellular and Molecular Life Sciences
  100. Integrative immunogenomic profiling identifies CALU as a brown adipocyte–linked modulator of progression and treatment response in pancreatic cancer
    Fang Wu, Xufan Cai, Zhenyuan Qian, Guangyuan Song, Xiao Zhang, Tao Ding, XU Weilang, Weilin Wang · 2026 · Discover Oncology